섬유근통증후군 = Fibromyalgia Syndrome

다국어 초록 (Multilingual Abstract)

Fibromyalgia is a chronic pain syndrome of unknown etiology that is characterized by diffuse musculoskeletal pain,fatigue, sleep disturbance, memory disturbance, and exaggerated tenderness over particular paired locations.
Fibromyalgia is found in 2% to 4% of the general population and more common in women, with symptoms usually appearing between 20 and 55 years of age. The diagnostic criteria for fibromyalgia syndrome established in 1990 by the American College of Rheumatology (ACR), includes widespread pain for at least 3 months and point tenderness upon the application of a 4 kg weight at 11 or more of the 18 characteristic tender points. The 2010 ACR preliminary diagnostic criteria have been developed, which are strongly correlated with the 1990 ACR criteria and provide an alternative approach to diagnosis. Patients with fibromyalgia syndrome have lower pain thresholds and experience an altered temporal summation to pain stimuli. The sensitization of pain perception occurs in the dorsal horn of patients with fibromyalgia. However, it is unknown whether sensitization is due to increased pain fiber facilitation, or decreased inhibition. Pregabalin is approved by the United States Food and Drug Administration for the management of fibromyalgia patients. Tricyclic antidepressants, cardiovascular exercise, cognitive behavioral therapy and patient education are also effective in reducing the pain experienced by fibromyalgia patients. This article provides an overview of fibromyalgia syndrome, which is currently thought to be partly responsible for chronic diffuse pain.

참고문헌 (Reference)

1 Tofferi JK, "Treatment of fibromyalgia with cyclobenzaprine : a meta-analysis" 51 : 9-13, 2004

2 Hauser W, "Treatment of fibromyalgia syndrome with gabapentin and pregabalin : a meta-analysis of randomized controlled trials" 145 : 69-81, 2009

3 Bennett RM, "Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain : a double-blind, randomized, placebo-controlled study" 114 : 537-545, 2003

4 Croft P, "The prevalence of chronic widespread pain in the general population" 20 : 710-713, 1993

5 Bennett GJ, "The morphology of dorsal column post-synaptic spinomedullary neurons in the cat" 224 : 568-574, 1984

6 Weir PT, "The incidence of fibromyalgia and its associated comorbidities : a population- based retrospective cohort study based on International Classification of Diseases, 9th Revision codes" 12 : 124-128, 2006

7 Young PA, "The anatomy of the spinal cord pain paths : A review" 9 : 28-38, 1986

8 Wolfe F, "The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity" 62 : 600-610, 2010

9 Wolfe F, "The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee" 33 : 160-172, 1990

10 Staud R, "Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome" 102 : 87-95, 2003

11 Ralston HR, "Synaptic organization of the spinothalamic tract projection to the thalamus with special reference to pain, In Advances in pain Research and Therapy. Vol. 6" Raven Press 1984

12 Coury F, "Rheumatoid arthritis and fibromyalgia : a frequent unrelated association complicating disease management" 36 : 58-62, 2009

13 Tunks E, "Regional soft tissue pains : alias myofascial pain?" 13 : 345-369, 1999

14 Goldenberg DL, "Randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia" 29 : 1371-1377, 1986

15 Crofford LJ, "Pregabalin for the treatment of fibromyalgia syndrome : results of a randomized, double-blind, placebo-controlled trial" 52 : 1264-1273, 2005

16 Croft P, "Population study of tender point counts and pain as evidence of fibromyalgia" 309 : 696-699, 1994

17 Krout KE, "Periaqueductal gray matter projection to the parabrachial nuelcus in the rat" 401 : 437-454, 1998

18 Melzack R, "Pain mechanisms : A new theory" 150 : 971-979, 1965

19 Basbaum AI, "Opiate and stimulus-produced analgesia : Functional anatomy of a medullospinal pathway" 73 : 4685-4688, 1976

20 Brodal A., "Neurological anatomy in relation to clinical medicine. 3rd ed" Oxford University Press 1981

21 Kosek E, "Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation(HNCS)in fibromyalgia patients and healthy subjects" 70 : 41-51, 1997

22 Cole JA, "Migraine, fibromyalgia and depression among people with IBS : a prevalence study" 6 : 26-, 2006

23 Goldenberg DL, "Management of fibromyalgia syndrome" 292 : 2388-2395, 2004

24 Raghavendra V, "Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy" 306 : 624-630, 2003

25 Rooks DS, "Group exercise, education, and combination self-management in women with fibromyalgia : a randomized trial" 167 : 2192-2200, 2007

26 Cook DB, "Functional imaging of pain in patients with primary fibromyalgia" 31 : 364-378, 2004

27 Goldenberg DL, "Fibromyalgia syndrome. An emerging but controversial condition" 257 : 2782-2787, 1987

28 Bannwarth B, "Fibromyalgia syndrome in the general population of France : a prevalence study" 76 : 184-187, 2009

29 Goldenberg DL, "Fibromyalgia syndrome a decade later : what have we learned?" 159 : 777-785, 1999

30 Katz RS, "Fibromyalgia diagnosis : a comparison of clinical, survey, and American College of Rheumatology criteria" 54 : 169-176, 2006

31 Marcus DA, "Fibromyalgia and headache : an epidemiological study supporting migraine as part of the fibromyalgia syndrome" 24 : 595-601, 2005

32 Busch AJ, "Exercise for fibromyalgia : a systemic review" 35 : 1130-1144, 2008

33 Watkins LR, "Evidence for the involvement of spinal cord glial in subcutaneous formalin induced hyperalgesia in the rat" 71 : 225-235, 1997

34 Carette S, "Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study" 29 : 655-659, 1986

35 Russell IJ, "Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder : results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial" 136 : 432-444, 2008

36 Bircan C, "Effects of muscle strengthening versus aerobic exercise program in fibromyalgia" 28 : 527-532, 2008

37 Gebhart GF, "Descending modulation of pain" 27 : 729-737, 2004

38 Gusi N, "Cost-utility of an 8-month aquatic training for women with fibromyalgia : a randomized controlled trial" 10 : 24-, 2008

39 Basbaum AI, "Conduction of the effects of noxious stimulation by short fiber multisynaptic systems of the spinal cord in rat" 40 : 699-716, 1973

40 Carette S, "Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia : A randomized, double-blind clinical trial" 37 : 32-40, 1994

41 Glass JM, "Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome : new trends and future directions" 8 : 425-429, 2006

42 White KP, "Cognitive behavioral treatment of fibromyalgia syndrome : a followup assessment" 22 : 717-721, 1995

43 Kato K, "Chronic widespread pain and its comorbidities : a population-based study" 166 : 1649-1654, 2006

44 Fields HL, "Central nervous system mechanism of pain modulation, In Wall and Melzak’s textbook of pain. 5th ed" Elsevier Churchill Livingstone 125-142, 2006

45 Fields HL, "Anatomy and physiology of a nociceptive modulatory system" 308 : 361-374, 1985

46 Basbaum AI., "Anatomical substrates of pain and pain modulation and their relationship to analgesic drugs, In Analgesics : Neurochemical, behavioral and clinical perspective" Raven Press 1984

47 Shleyfer E, "Accuracy of the diagnosis of fibromyalgia by family physicians : is the pendulum shifting?" 36 : 170-173, 2009

48 Staud R, "Abnormal sensitization and temporal summation of second pain(wind-up)in patients with fibromyalgia syndrome" 91 : 165-175, 2001

49 Branco JC, "A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia" 37 : 851-859, 2010